Efficient and scalable purification of mRNA using affinity chromatography

Cell & Gene Therapy Insights 2021; 7(3), 387


Published: 28 April 2021
Zoltan Gulyas

Watch the video or read the poster to learn how POROS™ Oligo (dT)25 Affinity Resin can help you achieve selective, scalable, and cGMP-compliant purification, including data on:

  • Recovery and impurity removal
  • Resin reuse and cleaning

About the speaker

Zoltan Gulyas has a MSc degree in chemical engineering, and graduated from the University of Technology and Economics in Budapest, Hungary. He started his career with Gedeon Richter Plc. in Budapest as a process development scientist, where his main responsibility was to develop purification methods for small molecular pharmaceuticals using preparative scale HPLC. After 3 years he joined the biologics development team to purity recombinant proteins and monoclonal antibodies. During his 5 years as DSP scientist Zoltan gathered experience in process development, scale-up, technology transfer, process validation, manufacturing and filing of biologics. In 2017 he joined Thermo Fisher Scientific as a Field Applications Specialist for Purification covering primarily Northern Europe, and he has been supporting the use of POROS and CaputreSelect products for recombinant proteins, mAbs and derivatives, viral vectors and vaccines for past 3 years.